Cancer Research  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 50, 1479-1483, March 1, 1990]
© 1990 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marques, L. A.
Right arrow Articles by Brentani, R. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marques, L. A.
Right arrow Articles by Brentani, R. R.

Independent Prognostic Value of Laminin Receptor Expression in Breast Cancer Survival

Lourdes A. Marques1, Eduardo L. F. Franco2, Humberto Torloni, M. Mitzi Brentani, J. Baptista da Silva-Neto and Ricardo R. Brentani3

Ludwig Institute for Cancer Research, São Paulo Branch [L. A. M., E. L. F. F., H. T., R. R. B.]; Laboratório de Oncologia Experimental, Departamento de Clinica Médica-FMUSP [L. A. M., M. M. B.]; and Departamento de Mastologia do Hospital A. C. Camargo [J. B. S-N.], São Paulo, Brazil

We studied the possible prognostic role of laminin, estrogen (ER), and progesterone (PR) receptors and other pathological factors in relation to the disease-free interval and overall survival of female breast carcinoma patients. Multivariate analyses of clinical and pathological data with respect to the above survival time variables were performed by Cox regression. The statistical dependence of prognosis on ER, PR, and tumor size was based on the discriminant cutoff value that could best distinguish between survival curves. Axillary nodal status was the most significant independent factor in the prediction of both disease-free interval and overall survival of these patients. Use of the information on laminin receptor expression, PR concentration, tumor size, lymphocytic infiltrate, and tumor necrosis improved significantly the prediction of the risk of recurrence. Patients with tumors expressing laminin receptors had 40% less risk of recurrence (P = 0.0209) than those with no expression. On the other hand, four covariates were independently predictive of the risk of death: axillary nodal status, lymphocytic infiltrate, PR and ER concentration. There was a marginally significant (10% level) interaction between tumor size and lymphocytic infiltrate with respect to the prediction of the risk of recurrence. The above sets of variables were used to classify patients into risk groups for the prediction of recurrence and death.

1 Recipient of a graduate fellowship from FAPESP (84/2752-5).

2 Present address: Institut Armand-Frappier, Université du Québec, Laval, Quebec, Canada.

3 To whom requests for reprints should be addressed, at Epidemiology and Biostatistics Unit, Ludwig Institute for Cancer Research, Rua Prof. Antonio Prudente, 109, 01509 São Paulo, Brazil.

Received 7/21/89. Revised 10/30/89. Accepted 11/27/89.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
B. Davidson, S. Konstantinovsky, S. Nielsen, H. P. Dong, A. Berner, M. Vyberg, and R. Reich
Altered Expression of Metastasis-Associated and Regulatory Molecules in Effusions from Breast Cancer Patients: A Novel Model for Tumor Progression
Clin. Cancer Res., November 1, 2004; 10(21): 7335 - 7346.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1990 by the American Association for Cancer Research.